Small Molecules, Diagnostics, Vaccines
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
225
NCT03887416
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
Phase: Phase 4
Role: Lead Sponsor
Start: Apr 12, 2019
Completion: Feb 29, 2020
Loading map...